KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

UiPath (PATH) Other Operating Expenses (2020 - 2026)

UiPath filings provide 7 years of Other Operating Expenses readings, the most recent being $178.2 million for Q1 2026.

  • Quarterly Other Operating Expenses rose 0.76% to $178.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $683.3 million through Jan 2026, down 7.47% year-over-year, with the annual reading at $683.3 million for FY2026, 7.47% down from the prior year.
  • Other Operating Expenses hit $178.2 million in Q1 2026 for UiPath, down from $179.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $194.3 million in Q3 2024 and bottomed at $156.5 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is $177.1 million, with a median of $178.2 million recorded in 2026.
  • The largest annual shift saw Other Operating Expenses soared 75.85% in 2022 before it decreased 15.48% in 2023.
  • UiPath's Other Operating Expenses stood at $156.5 million in 2022, then rose by 22.25% to $191.3 million in 2023, then decreased by 2.14% to $187.2 million in 2024, then dropped by 4.27% to $179.2 million in 2025, then decreased by 0.56% to $178.2 million in 2026.
  • Per Business Quant, the three most recent readings for PATH's Other Operating Expenses are $178.2 million (Q1 2026), $179.2 million (Q4 2025), and $166.3 million (Q3 2025).